Jonathan W Riess

16PUBLICATIONS

232CO-AUTHORS

Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markersInnate immunity

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (16)

Sort by Publication Date:

|Jun 03, 2026

Resistance to Immune Checkpoint Inhibitor Treatment in Non-Small Cell Lung Cancer Clinical Trials: A Perspective From Lung-MAP Investigators.

|Mar 06, 2026

Genomic Profiling of Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer Post-Progression on First-Line Osimertinib: Phase II ORCHARD Study.

Helena A Yu, Kwan Ho Tang, Aleksandra A Markovets

|Jan 15, 2026

Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in RET-Altered Solid Tumors: Analysis of the RETgistry Global Consortium.

Sarah Waliany, Alissa J Cooper, Stephen V Liu

|Oct 29, 2025

Diversity of BRAF mutations in non-small cell lung cancer and implications on treatment.

Kevin Lu, John Paul Shen, Fernando J Lopez-Diaz

|Oct 28, 2025

Longitudinal Plasma Lipidomics Reveals Distinct Signatures Following Surgery in Patients with Glioblastoma.

John Paul Aboubechara, Yin Liu, Oliver Fiehn

|Oct 24, 2025

Actionable mutations and targeted therapy in non-small cell lung cancer among Latin American and Hispanic patients: a systematic literature review of prognosis and meta-analysis.

Juan Pablo Castañeda-González, Jonathan W Riess, María Paula Gómez-Gómez

Pageof 3

Frequent Collaborators

Sarah B Goldberg

David R Gandara

Philip C Mack

Sandip Pravin Patel

Collin M Blakely

Alissa J Cooper

Ticiana A Leal

Michael L Cheng

Shirish M Gadgeel

Jhanelle E Gray

Frequent Collaborators

Sarah B Goldberg

David R Gandara

Philip C Mack

Sandip Pravin Patel